Abraham Ceesay Pacira Bio Sciences, Inc. (PCRX) insider trading activity

PCRX Quotes by TradingView

Abraham Ceesay is Director of Pacira BioSciences, Inc.. Currently has a direct ownership of 9,039 shares of PCRX, which is worth approximately $237,725. The most recent transaction as insider was on Sep 04, 2025, when has been sold 2,354 shares (Common Stock) at a price of $27.19 per share, resulting in proceeds of $64,005. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.04K
72.83% 3M change
72.83% 12M change
Total Value Held $237,725

Abraham Ceesay Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 04 2025
SELL
Open market or private sale
$64,005 $27.19 p/Share
2,354 Reduced 20.66%
9,039 Common Stock
Jun 11 2025
BUY
Grant, award, or other acquisition
-
6,163 Added 35.1%
11,393 Common Stock
Jun 12 2024
BUY
Grant, award, or other acquisition
-
5,230 Added 50.0%
5,230 Common Stock

Also insider at

CERE
Cerevel Therapeutics Holdings, Inc. Healthcare
President
RAPP
Rapport Therapeutics, Inc.
Chief Executive Officer
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Healthcare
Director
AC

Abraham Ceesay

Director
Cambridge, MA

Track Institutional and Insider Activities on PCRX

Follow Pacira BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

News

Receive news related to Pacira BioSciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PCRX